Salawati Mansor1*, Asmadamia Abdul Aziz1, Jamiila Ismail1, Koay Bee Tee1, Nur Fatini Che Shamsudin1, Tengku Norminhalina Tan Mansor1, Nur Izzati Sariyah Saadon1, Siti Fatimah Mat Ali1, Phiong Ying Hui1, Wan Nurul Ain Mat Asuar1, Nurul Syafiqah1, Norfarhana Khairul Fahmy1, Zurina Shamsuddin1, Muhammad Zhafri Md Zakariah1, Adibah Hanis Zainudin1 and Norhazlin Mustafa1
1. Transplantation Immunology Unit, Allergy and Immunology Research Centre, Institute for Medical Research, National Institute of Health, Ministry of Health, 40170 Shah Alam, Selangor, Malaysia
*Corresponding author: Salawati Mansor.
ABSTRACT
INTRODUCTION: Complement-Dependent Cytotoxicity (CDC) crossmatch is an essential in vitro functional assay in solid organ transplantation. A positive CDC result strongly predicts hyperacute rejection and is a contraindication for transplantation. Conventional CDC employs eosin staining with formalin fixation, but limited contrast may hinder interpretation. FluoroQuench, a fluorescent stain, was evaluated as an alternative to enhance visualization of cytotoxicity.
OBJECTIVE(S): To compare and evaluate the performance of eosin and FluoroQuench staining in detecting cytotoxic reactions during CDC crossmatch in kidney transplant candidates.
MATERIALS & METHODS: From 2023 to 2024, 61 CDC crossmatch tests were conducted using patient sera against donor T lymphocytes. Duplicate CDC Terasaki plates were stained using eosin and FluoroQuench staining (acridine orange for live cells; ethidium bromide for dead cells). Plates were incubated at 4˚C, room temperature, and 37˚C. Dithiothreitol (DTT) treatment was performed to identify IgM antibodies and Human Leukocyte Antigen (HLA) antibody test was performed to identify the type and level of IgG donor-specific antibodies (DSAs) present in the patient's sera.
RESULTS: Among 61 tests, 6 were CDC-positive and 55 CDC-negative. Both staining methods showed 100% concordance. DTT treatment confirmed IgM involvement in two samples and IgG presence in the remaining four. Further investigation with HLA antibody tests revealed significantly high levels of IgG antibodies against HLA Class I and II antigens, namely DSAs, in the IgG-positive group.
CONCLUSION: FluoroQuench staining showed perfect concordance with eosin staining, while providing better visualization and clearer distinction between live (green) and dead (red) cells. Its enhanced contrast supports more accurate interpretation, making it a practical and advantageous alternative for CDC crossmatch staining.
KEYWORDS: Complement-dependent Cytotoxicity (CDC) Crossmatch, Eosin, FluoroQuench, Human Leukocyte Antigen (HLA) and Donor Specific Antibodies (DSA)


